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Acute pulmonary embolism is a substantial cause of morbidity and death. Although the
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines recommend surgical pulmonary embolectomy in patients with acute pulmonary embolism
associated with hypotension, there are few reports of 30-day mortality rates.
We performed a retrospective review of acute pulmonary embolectomy procedures
performed in 96 consecutive patients who had severe, globally hypokinetic right ventricular dysfunction as determined by transthoracic echocardiography. Data on patients who
were treated from January 2003 through December 2011 were derived from health system databases of the New York State Cardiac Surgery Reporting System and the Society
of Thoracic Surgeons. The data represent procedures performed at 3 tertiary care facilities
within a large health system operating in the New York City metropolitan area.
The overall 30-day mortality rate was 4.2%. Most patients (68 [73.9%]) were discharged home or to rehabilitation facilities (23 [25%]). Hemodynamically stable patients
with severe, globally hypokinetic right ventricular dysfunction had a 30-day mortality rate
of 1.4%, with a postoperative mean length of stay of 9.1 days. Comparable findings for
hemodynamically unstable patients were 12.5% and 13.4 days, respectively.
Acute pulmonary embolectomy can be a viable procedure for patients with severe,
globally hypokinetic right ventricular dysfunction, with or without hemodynamic compromise; however, caution is warranted. Our outcomes might be dependent upon institutional capability, experience, surgical ability, and careful patient selection. (Tex Heart Inst
J 2015;42(1):25-9)

A

lthough pulmonary embolectomies have been attempted since Trendelenburg first proposed their use in 1908, Steenburg and colleagues in 1958
were first to perform a successful traditional embolectomy in the United
States.1,2 This procedure has been associated with excessive mortality rates, persistent
right heart failure, intra-alveolar and interstitial pulmonary edema, and massive parenchymal and intrabronchial hemorrhage.1-3 It is not surprising, then, that the mainstay
treatment in recent times has been nonsurgical therapy.
Although most studies show historically high mortality rates (32% on the basis of
pooled data from 30 studies and 1,047 patients from 1961 through 1984), recent increases in the effectiveness of surgical techniques have resulted in lower mortality rates
for pulmonary embolectomies.4,5 For example, a surgical approach described by Aklog
and colleagues6 resulted in an 11% mortality rate among 29 patients, over a 3-year period of study. All patients had anatomically extensive embolism and moderate-to-severe
right ventricular (RV) dysfunction. Other investigators have shown similar results. For
example, Lehnert and associates, in 33 patients who underwent embolectomy, achieved
a 30-day mortality rate of 6% and a 12-year survival rate of 80%.7 Kadner and coworkers also produced a low mortality rate of just 8% in 25 patients over a 7-year period.8
Schoepf and colleagues’ study of patients with RV enlargement showed a 30-day mortality rate of 15.6%, compared with 7.7% when RV enlargement was not present.9
The American College of Chest Physicians Evidence-Based Clinical Practice Guidelines recommend surgical pulmonary embolectomy in patients with acute pulmonary
embolism (PE) associated with hypotension, if 1) patients have contraindications to
thrombolysis; 2) patients have undergone failure of thrombolysis or catheter-assisted
embolectomy; or 3) patients are in a state of shock that is likely to result in death before
thrombolysis can take effect; and 4) the surgeon possesses appropriate expertise, and
obtainable or accessible resources are ready for use.10 Despite the above recommendation from the American College of Chest Physicians, surgical pulmonary embolectomy
http://dx.doi.org/10.14503/THIJ-13-3877
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in patients with acute PE associated with hypotension
is still less frequently used than is thrombolytic therapy,
and there are few reports of 30-day mortality rates.
The purpose of this study is to describe our experience over a 9-year period with acute-PE patients who
presented with severe (life-threatening), globally hypokinetic RV dysfunction, as determined by transthoracic
echocardiography (TTE). We herein provide preliminary descriptive analysis of early pulmonary embolectomy in hemodynamically stable and unstable patients
who presented with acute pulmonary embolus causative
of RV compromise.

Patients and Methods
This study was conducted in compliance with the human-study guidelines of the authors’ institutions and in
compliance with U.S. Food and Drug Administration
guidelines. The protocol was approved by the institutional review board (IRB #11-342B) and was granted a
waiver of informed consent. We retrospectively studied
the cases of 96 consecutive patients with acute, centrally
located pulmonary embolus, and severe, globally hypokinetic RV dysfunction who had undergone pulmonary
embolectomy from January 2003 through December
2011. This reflected the experience of 3 tertiary care
facilities within a large health system operating in the
New York City metropolitan area. The experience of
each surgeon performing surgical embolectomies at our
institutions varies; of the 13 surgeons whose data were
included, at least 8 had more than 15 years of experience.
Catheter-based embolectomy is typically not performed
at our institutions. Data were derived from health system databases of the New York State Cardiac Surgery
Reporting System and the Society of Thoracic Surgeons.
Outcome Variables

The major outcome variable was hospital death, defined
as death within 30 days of the procedure or death during the index hospitalization (beyond 30 days, if still
hospitalized). Other outcome variables included postoperative length of stay (LOS), discharge location, readmission status, and postoperative complications.
Diagnostic and Therapeutic Algorithm

All patients were evaluated for RV dysfunction, by
means of TTE. Indications for surgery included severe,
globally hypokinetic RV dysfunction on TTE, and
computed-tomographic-angiography (CTA)–documented PE, with either a large clot burden in the main
pulmonary arteries (PAs) or a saddle embolism. This is
consistent with the 2014 definition of intermediate-risk
PE.11
No patients in this group had a history of chronic pulmonary thromboembolic disease or evidence of chronic
disease on CTA. All TTEs were completed by attending
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echocardiologists. The following measurements were
typically taken: RV size in the 4-chamber view (RV
enlargement was defined as a ratio of RV diameter to
left ventricular diameter of >0.9), presence of tricuspid
regurgitation, systolic PA pressure, tricuspid annular
plane systolic excursion, and septal shift. In addition,
patients with McConnell’s sign or abnormal right atrial
size were evaluated.
Most of the patients were transferred from outlying hospitals or from other in-hospital services, with a
completed diagnostic CTA scan of the chest accompanied by intravenous administration of contrast material
during the venous phase. For the few who were transferred without such a scan, one was obtained soon after
transfer. Immediately after a CTA revealed main PA or
saddle PA embolism, heparin therapy was initiated and
a TTE was obtained to detect and evaluate RV strain
or compromise.
All patients who underwent pulmonary embolectomy had either a saddle embolus or an obstructing
left or right main PA embolus with severe, globally
hypokinetic RV strain. All the patients who underwent an embolectomy did so within one hour. Pulmonary embolectomy was performed through a primary
sternal splitting incision or partial upper sternotomy,
with use of ascending aortic cardiopulmonary bypass
(CPB) and either dual-stage venous CPB or separate
superior and inferior caval cannulation. All were done
in patients with a beating heart at normothermia. We
also have routinely used pericardial carbon dioxide insufflation to avoid pulmonary air entrapment and the
release of endothelium-derived cytokines, which can
contribute to “leaky” endothelium and noncardiogenic
pulmonary edema.12-16 Our approach was to avoid ischemic injury to a stunned RV, keeping the right side
of the heart unloaded and well-perfused, and avoiding blind instrumentation of fragile PAs. A pulmonary
arteriotomy and clot extraction was performed under
direct vision with the use of gallstone forceps, sponge
ring forceps, or both.
On CPB with the right side of the heart decompressed, the PA was double-looped with use of silastic
vascular tape proximal to the bifurcation; then traction
was applied. The PA was incised longitudinally from its
confluence to just above the pulmonary valve (within
1 to 2 cm of the valve). The clot was retrieved with
use of a common duct basket forceps and suction tip.
When all large fragments had been removed, the PAs
were flushed with saline solution and the pulmonary
arteriotomy was closed with use of fine Prolene suture.
Temporary pacing wires and mediastinal drains were
placed. The wound was closed in a normal fashion.
Statistical Analysis

Rates were computed by means of standard methods
for estimating proportions and by applying exact 95%
Volume 42, Number 1, 2015

confidence intervals. Otherwise, simple descriptive statistics were given. Comparisons of hemodynamically
stable versus unstable patients were made by means of
the Fisher exact test for categorical data and the MannWhitney test for continuous data. A P value of less than
0.05 was considered statistically significant. Data analysis was conducted with the use of SAS software version
9.2 (SAS Institute, Inc.; Cary, NC).

Results
Results for Entire Cohort

Our sample consisted of 96 patients. Seventy-two patients (75%) were stable (systolic blood pressure, >90
mmHg), and 24 patients (25%) were unstable (systolic
blood pressure, <90 mmHg) and therefore placed on
vasopressors. For the 3 facilities in total, 43 patients
(44.8%) had contraindications to tissue plasminogen
activator (tPA). All patients had severe, globally hypokinetic RV dysfunction on preoperative bedside TTE
and almost all (93 patients [96.9%]) had severe RV enlargement. The average grade of tricuspid regurgitation
was 1.85/4 and the average estimated pulmonary systolic pressure was 58.4 mmHg. All patients had saddle or
bilateral main PA emboli on CTA and exhibited severe,
globally hypokinetic RV strain and dysfunction, as determined by TTE and as confirmed by transesophageal
echocardiography in the operating room. One patient
experienced, in transit, emboli in the RV cavity, and 5
patients (5.2%) went on to surgery after having received
tPA preoperatively, because they showed no improvement in RV strain. Seven patients (7.2%) needed repeat
intervention: 2 (2.1%) for recurring PE after inferior
vena cava filter placement and 5 (5.2%) for symptomatic pericardial effusion.
Sixty patients were male (62.5%) and 36 were female
(37.5%) (Table I). The mean age at admission was 57.7
± 14.5 years (median age, 59.3 yr); 53 (55.2%) were
younger than 60 years of age. Seventy-two were white
(75%) and 92 were non-Hispanic (95.8%). The total
mean LOS was 11.7 ± 12.6 days (median, 8 d) (Table
II). The postoperative mean LOS was 10.2 ± 12 days
(median, 7 d). Although we cannot surmise that every
patient with a LOS of 0 came to the emergency department, we determined on the basis of admission and
surgery dates that 42 of these 96 patients (44%) had a
LOS before surgery of 0 days. This is a conservative
estimate of how many patients were referred from the
emergency department or were transferred from another
institution.
The 30-day mortality rate was 4.2% (95% confidence interval, 1.1%–10.3%); 4 of the 96 patients died
(none in facility 1, 3 in facility 2, and 1 in facility 3).
Sixty-eight patients were discharged home (73.9%) and
23 to rehabilitation facilities (25%) (Table III). The
total mean time on the ventilator, postoperatively, was
Texas Heart Institute Journal

32.9 ± 81 hours, and the total mean CPB time was 38.5
± 23.8 minutes.
Overall, there were few complications: 2 patients
(2.9%) had a postoperative cardiac arrest, 7 (7.3%) had
to undergo an unplanned cardiac reoperation or interventional procedure, 7 (7.3%) had respiratory failure as
defined by mechanical ventilation time >48 hours, and
3 (3.1%) experienced gastrointestinal bleeding. With
regard to readmission, 8 patients (11.6%) were readmitted; 4 (50%) of those readmissions were secondary to
pericardial effusions and took the form of hemopericardium—most likely caused by aggressive early oral anticoagulation or by systemic intravenous anticoagulation
begun early in the perioperative period.
Comparison between Hemodynamically
Stable and Unstable Patients

We define unstable patients as those requiring vasopressors to compensate for systolic blood pressures of
<90 mmHg. Given that unstable patients have usually
had high morbidity and mortality rates, whether with
surgery or with tPA administration, we looked specifically at outcomes among this high-risk population. As
seen in Table II, hemodynamically stable patients had
significantly lower postoperative and total lengths of
stay (both P <0.001) than did unstable patients. UnTABLE I. Characteristics of the 96 Patients
Variable

Value

Male

60 (62.5)

Female

36 (37.5)

Age at admission (yr)
<60
60–70
71–80
81–90

57.7 ± 14.5
(median, 59.3)
53 (55.2)
22 (22.9)
18 (18.8)
3 (3.1)

Race
White
Black

72 (75)
24 (25)

Ethnicity
Non-Hispanic
Hispanic

92 (95.8)
4 (4.2)

Weight (kg)
45–68
69–90
≥91
Height (cm)
<152
152–165
166–183
≥184

99.2 ± 22.5
(median, 100)
7 (7.3)
26 (27.1)
63 (65.6)
173.1 ± 11.9
(median, 175)
3 (3.1)
26 (27.1)
52 (54.2)
15 (15.6)

Data are presented as mean ± SD or as number and percentage,
unless otherwise stated.
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stable patients had significantly longer CPB time and
postoperative total ventilator hours (both P=0.002)
than did stable patients (Table III). There was a signif‑

icant relationship between the stability of patients and
the discharge destination, with stable patients more
likely to be discharged home (P=0.004).

TABLE II. Lengths of Stay for All Patients and for Hemodynamically Stable versus Unstable Patients
Length of Stay (d)

All Patients
N=96

Stable
n=72

Unstable
n=24

P Value*

Preoperative
Mean ± SD (median)
≤5
6–10
11–15
16–20
≥21

1.5 ± 3 (1)

1.3 ± 2.5 (1)

90 (93.8)
3 (3.1)
1 (1)
2 (2.1)
0		

69 (95.8)
2 (2.8)
0		
1 (1.4)
0		

21 (87.5)
1 (4.2)
1 (4.2)
1 (4.2)
0		

—
—
—
—
—

Postoperative
Mean ± SD (median)
≤5
6–10
11–15
16–20
≥21

10.2 ± 12 (7)

9.1 ± 12.8 (6)

13.4 ± 8.4 (10)

<0.001

Total
Mean ± SD (median)
≤5
6–10
11–15
16–20
≥21

11.7 ± 12.6 (8)

32
40
12
4
8

21
42
15
8
10

(33.3)
(41.7)
(12.5)
(4.2)
(8.3)

(21.9)
(43.8)
(15.6)
(8.3)
(10.4)

30
29
8
1
4

(41.7)
(40.3)
(11.1)
(1.4)
(5.6)

10.4 ± 13.4 (7)
19
35
10
4
4

(26.4)
(48.6)
(13.9)
(5.6)
(5.6)

2.4 ± 4 (1)

2
11
4
3
4

0.201

(8.3)
(45.8)
(16.7)
(12.5)
(16.7)

—
—
—
—
—

15.8 ± 8.9 (14.5)

<0.001

2
7
5
4
6

(8.3)
(29.2)
(20.8)
(16.7)
(25)

—
—
—
—
—

*Hemodynamically stable versus unstable patients
Data are presented as mean ± SD or as number and percentage, unless otherwise stated. P <0.05 was considered statistically significant.

TABLE III. Outcomes for All Patients and for Preoperatively Hemodynamically Stable versus Unstable Patients
Variable
30-day death

All Patients
N=96
4

(4.2)

Stable
n=72
1 (1.4)

Unstable
n=24

P Value*

3 (12.5)

0.047

Postoperative ventilation
32.9 ± 81 (11)
23.7 ± 50.4 (10)
71.8 ± 152.2 (26)
Mean ± SD (median), hr				

0.002

Cardiopulmonary bypass time
38.5 ± 23.8 (32)
35 ± 23.5 (29)
48.8 ± 21.8 (48)
Mean ± SD (median), min				

0.002

Discharge destination
Home
Rehabilitation
Other
Complications
Postoperative cardiac arrest**
Unplanned cardiac reoperation
or interventional procedure
Respiratory failure
Gastrointestinal bleeding
Readmission status**
Readmitted
Not readmitted
Died

68 (73.9)
23 (25)
1 (1.1)

58 (81.7)
12 (16.9)
1 (1.4)

10 (47.6)
11 (52.4)
0

0.004

2
7

(2.9)
(7.3)

2 (3.6)
4 (5.6)

0		
3 (12.5)

1.000
0.361

7
3

(7.3)
(3.1)

4 (5.6)
0		

3 (12.5)
3 (12.5)

0.361
0.014

8 (11.6)
57 (82.6)
4 (5.8)

7 (13)
46 (85.2)
1 (1.9)

1 (6.7)
11 (73.3)
3 (20)

0.046

*Hemodynamically stable versus unstable patients
**Before 2007, data on some outcome variables were not routinely collected and were missing from the databases. The data were
available for only 68 of the postoperative cardiac arrest variable, and for 69 of the readmission status variable of the total cohort of
96 patients.
Data are presented as mean ± SD or as number and percentage, unless otherwise stated. P <0.05 was considered statistically significant.
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Discussion
Overall, our findings suggest that pulmonary embolectomy is a viable approach to consider as part of the
treatment repertoire. Meyer and colleagues’ recent randomized double-blinded study 11 of fibrinolytic therapy
in intermediate-risk PE patients who were evaluated by
means of echocardiography or computed tomography
found that although fibrinolysis prevents hemodynamic
decompensation, it increases the risk of major hemorrhage and stroke. It is our hypothesis that patients with
contraindications to thrombolytic use in this intermediate-risk group can benefit from surgical embolectomy. Our experience suggests that the appropriateness
of surgery for acute PE revolves around 3 important
principles: the significance of RV dysfunction on TTE
or CTA, the presence of contraindications for thrombolytic therapy, and the safety of the surgical procedure
being offered.
As we say above, the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 10
recommend surgical pulmonary embolectomy in patients with acute PE that is associated with hypotension; however, this procedure is still not frequently used
and there are few reports of the 30-day mortality rate.
The results of our study support Aklog and colleagues’
previous findings that pulmonary embolectomy can be
performed with low mortality rates.6 Schoepf and associates showed a 30-day mortality rate of 15.6% for
patients with RV enlargement; patients without RV
enlargement had a mortality rate of 7.7%.9 Our overall
mortality rate of 4 (4.2%) is lower than those of previous studies, in which patients were treated with embolectomy or thrombolytic agents.
Limitations of the Study

Our study is not without limitations. The retrospective design used in this study relies on the accuracy of
written records, and missing or unavailable data could
have affected the results. In addition, there was no comparison group of medically treated patients. For these
reasons, we cannot definitively state, on the basis of our
evidence, that an early pulmonary embolectomy is a safe
and effective procedure. It is also important to take into
account the extent to which our results are dependent
on the capability of our institutions, the extensive experience and ability of our surgeons, and careful patient
selection.
Conclusion

Early pulmonary embolectomy in patients presenting
with acute PE—manifested by severe, globally hypokinetic RV dysfunction, as determined initially by means
of TTE—might be a viable alternative to thrombolytic
therapy, but caution is warranted. We must continue,
through large-scale studies, to identify factors that can
Texas Heart Institute Journal

influence the outcome of this potentially life-saving procedure.
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